Rifampicin resistance in tuberculosis outbreak, London, England

Emerging Infectious Diseases

Volumn 11, Issue 6, 2005, Pages 931-934

  Jenkins, Claire ^a   Claxton, Alleyna P ^b   Shorten, Robert J ^a   McHugh, Timothy D ^a   Gillespie, Stephen H ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; UNITED KINGDOM;

EID: 19344374855     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1106.050118     Document Type: Article

References (12)

1. Ruddy MC, Davies AP, Yates MD, Yates S, Balasegaram S, Drabu Y, et al. Outbreak of isoniazid resistant tuberculosis in north London. Thorax. 2004; 59:279-85.
2. Davies AP, Ruddy MC, Neely F, Ruggles R, on behalf of the Outbreak Control Committee. Outbreak of isoniazid resistant tuberculosis in north London 1999-2004. Dulwich, London: Health Protection Agency Regional Epidemiology Unit; 2004.
3. Yates MD, Drobniewski FA, Wilson SM. Evaluation of a rapid PCR-based epidemiological typing method for routine studies of Mycobacterium tuberculosis. J Clin Microbiol. 2002;40:712-4.
4. Jin DJ, Gross CA. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol. 1988;202:45-58.
5. Miller LP, Crawford JT, Shinnick TM. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1994;38:805-11.
6. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998;79:3-29.
7. Heep M, Brandstatter B, Rieger U, Lehn N, Richter E, Rusch-Gerdes S, et al. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol. 2001;39:107-10.
8. Kiepiela P, Bishop K, Kormuth E, Roux L, York DF. Comparison of PCR-heteroduplex characterization by automated DNA sequencing and line probe assay for the detection of rifampicin resistance in Mycobacterium tuberculosis isolates from KwaZulu-Natal, South Africa. Microb Drug Resist. 1998;4:263-9.
9. Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol. 1999;37:2663-6.
10. Yang B, Koga H, Ohno H, Ogawa K, Fukuda M, Hirakata Y, et al. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother. 1998;42:621-8.
11. Caugant DA, Sandven P, Eng J, Jeque JT, Tonjum T. Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique. Microb Drug Resist. 1995;1:321-6.
12. Cockerill FR 3rd, Williams DE, Eisenach KD, Kline BC, Miller LK, Stockman L, et al. Prospective evaluation of the utility of molecular techniques for diagnosing nosocomial transmission of multidrug-resistant tuberculosis. Mayo Clin Proc. 1996;71:221-9.